Gene-Editing Therapy for Genetic Retinal Blindness Shows Favorable Safety Outcomes
- Posted on: May 24 2024
- Leave a response
No significant adverse effects were seen in a small cohort of patients after receipt of a CRISPR-derived agent designed to target CEP290-associated inherited retinal degeneration.
Source: AAO
Posted in: Uncategorized
